is overweight and more than 2 in 5 adults have obesity, according to the National Institute of Diabetes and Digestive and Kidney Diseases
NCBI However, Wegovy and Ozempic are not approved for exactly the same conditions: Ozempic (semaglutide injection) is FDA-approved for adults with type 2 diabetes to: Improve blood sugar control, and Reduce the risk of major cardiovascular events (heart attack, stroke, or cardiovascular death) in adults with type 2 diabetes and established cardiovascular disease
Started in late March at 2.5mg weekly
While GLP-1RAs effectively improve glycemic control and cause weight loss, potential safety concerns have arisen over the years
A complete plan may include nutrition guidance, movement goals, hydration, sleep support, medication review, and follow-up appointments
Clinical data revealed that beta-cell function had partly recovered from diagnosis to study inclusion in participants with well-regulated SIDD but remained low in those who were dysregulated